5% Off
Ferinject100 mg
Unimed Unihealth MFG. Ltd.
৳946.90
Out Of Stock
Generic medicine
Ferric Carboxymaltose: Brands, Price & Uses in Bangladesh
Ferric Carboxymaltose is an intravenous (IV) iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in the following settings: Established / Approved Uses Iron…
About Ferric Carboxymaltose
Indications of Ferric Carboxymaltose
Ferric Carboxymaltose is an intravenous (IV) iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in the following settings:
Established / Approved Uses
- Iron deficiency anemia in adult and pediatric patients (1 year of age and older) who have intolerance to oral iron or who have had an unsatisfactory response to oral iron.
- Iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease (CKD).
Guideline-Supported Use
- Iron deficiency in adult patients with chronic heart failure (New York Heart Association Class II/III) to improve exercise capacity, used as an adjunct alongside standard heart failure therapy rather than as monotherapy.
Ferric Carboxymaltose is not indicated for anemias not caused by iron deficiency and should not be used when iron deficiency has not been confirmed.
Dosage & Administration of Ferric Carboxymaltose
Ferric Carboxymaltose is administered only by intravenous injection or infusion by a healthcare professional. Dosing is individualized by body weight and, in some indications, by hemoglobin level. See Dosage and Administration sections below for details. A summary of per-indication dosing is provided here:
| Indication | Population | Typical Dosing |
|---|---|---|
| Iron deficiency anemia (oral iron intolerant/inadequate response) | Adults and children ≥1 year, ≥50 kg | 750 mg IV per dose, in 2 doses at least 7 days apart (cumulative 1,500 mg per course); or up to 1,000 mg as a single dose in adults, depending on product labeling |
| Iron deficiency anemia | Patients <50 kg | 15 mg/kg IV per dose, in 2 doses at least 7 days apart |
| Non-dialysis-dependent CKD | Adults | Same weight-based dosing as above |
| Chronic heart failure (NYHA II/III) with iron deficiency | Adults | Dosing individualized by baseline hemoglobin and body weight, per approved dosing table; maintenance doses may be given at intervals if iron stores remain low |
Do not exceed the maximum single-dose or cumulative-dose limits specified in the approved product labeling. Repeat courses should only be given if iron deficiency recurs, and phosphate levels should be checked before repeat dosing (see Precautions and Warnings).
Side Effects of Ferric Carboxymaltose
The most common side effects of Ferric Carboxymaltose include:
- Nausea
- Headache
- Dizziness
- Transient hypertension and flushing (see Precautions and Warnings for details)
- Injection site reactions (discoloration, pain, bruising)
- Hypophosphatemia (see Precautions and Warnings for full explanation)
Less common effects include altered taste (dysgeusia), tachycardia, hypotension, dyspnea, rash, and myalgia.
Rare but serious effects include hypersensitivity reactions up to and including anaphylaxis (see Contraindications and Precautions and Warnings), and, with repeated high cumulative dosing, symptomatic hypophosphatemic osteomalacia.
Contraindications of Ferric Carboxymaltose
Ferric Carboxymaltose is contraindicated in patients with:
- Known hypersensitivity to Ferric Carboxymaltose or to any of its excipients.
- Evidence of iron overload or disturbances in the body's utilization of iron (e.g., hemochromatosis, hemosiderosis).
Ferric Carboxymaltose should not be used in patients with anemia not caused by iron deficiency.
Frequently Asked Questions about Ferric Carboxymaltose
What is Ferric Carboxymaltose used for?
Ferric Carboxymaltose is an intravenous iron medicine used to treat iron deficiency anemia in people who cannot tolerate or do not respond well to oral iron tablets, in adults with certain chronic kidney disease, and as an add-on treatment for iron deficiency in some patients with chronic heart failure.
How is Ferric Carboxymaltose given?
Ferric Carboxymaltose is given only by a doctor or nurse, as a slow injection directly into a vein or as an infusion (drip) diluted in saline. It is not a tablet or an at-home injection; it must be given in a clinical setting equipped to handle allergic reactions.
What are the most serious risks of Ferric Carboxymaltose?
The most serious risks of Ferric Carboxymaltose are severe allergic (hypersensitivity) reactions, including anaphylaxis, which is why it is given only where resuscitation equipment and trained staff are available and why patients are monitored for at least 30 minutes after each dose. Ferric Carboxymaltose can also lower blood phosphate levels (hypophosphatemia), which in rare cases with repeated dosing has caused bone softening (osteomalacia) and fractures, so your doctor may check your blood phosphate, especially before a repeat dose.
Can Ferric Carboxymaltose be used during pregnancy or breastfeeding?
Ferric Carboxymaltose should be used in pregnancy only if clearly needed and if the potential benefit outweighs the potential risk to the fetus, and it is generally avoided in the first trimester. Allergic reactions during infusion can rarely affect the fetus, especially later in pregnancy. Small amounts may pass into breast milk; a physician should weigh the benefits of breastfeeding against your need for treatment. Always consult your physician before use in pregnancy or while breastfeeding.
Are there side effects I should watch for after receiving Ferric Carboxymaltose?
After receiving Ferric Carboxymaltose, you may notice nausea, headache, dizziness, a brief rise in blood pressure with flushing, or discoloration/discomfort at the injection site; these are usually mild and temporary. Seek immediate medical attention if you develop signs of a serious allergic reaction such as difficulty breathing, swelling of the face or throat, severe rash, or fainting.
What should I do if too much Ferric Carboxymaltose is given or an overdose is suspected?
An overdose of Ferric Carboxymaltose can lead to excess iron accumulation in the body (iron overload) and, with repeated excessive dosing, bone problems from low phosphate. If an overdose or a serious reaction is suspected, seek immediate medical attention or contact emergency services right away; treatment will be supportive and guided by a physician.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.